The invention relates generally to medical catheters, and particularly to catheter assemblies suitable for use in the treatment of hydrocephalus.
Hydrocephalus is a common disorder that is associated with enlarged ventricles in the brain and can be experienced by individuals of all ages. Typically, treatment of hydrocephalus involves placing a shunt catheter, such as a ventriculo-peritoneal shunt (VP shunt) system in the brain. Ventriculo-atrial and ventriculo-pleural shut placements also may be performed in some cases.
According to one embodiment, a catheter assembly includes a sheath arranged to be permanently attached to a portion of a brain, a catheter slidably disposed in the sheath, and a connector connected to the sheath and catheter, the connector having one or more ports to allow fluid to be transferred into and out of the brain.
According to another embodiment, a method of installing a catheter assembly in a brain of a patient is disclosed. The method includes installing a sheath into the brain of the patient to create a permanent passageway between a surface of the brain and a ventricle within the brain, and removably inserting a catheter into the ventricle via the sheath.
According to another embodiment, a shunt is disclosed. The shunt includes a catheter assembly arranged to be installed in a patient's brain, a shunt valve, and a distal catheter assembly, the distal catheter assembly including a distal catheter sheath and a distal catheter slidingly disposed in the distal catheter sheath. The distal catheter sheath is arranged to be permanently subcutaneously attached to at least one of a neck, a chest and an abdomen of the patient.
According to still another embodiment, a shunt includes a catheter assembly including a sheath arranged to be permanently attached to a portion of a brain and a catheter slidably disposed in the sheath, a shunt valve, and a distal catheter.
It should be appreciated that the foregoing concepts, and additional concepts discussed below, may be arranged in any suitable combination, as the present disclosure is not limited in this respect.
The foregoing and other aspects, embodiments, and features of the present teachings can be more fully understood from the following description in conjunction with the accompanying drawings.
The objects and features of the invention can be better understood with reference to the drawings described below, and the claims. The drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention
In the drawings, each identical or nearly identical component that is illustrated in various figures is represented by a like numeral. For purposes of clarity, not every component may be labeled in every drawing. In the drawings:
Hydrocephalus is a disorder that is associated with enlarged ventricles, the fluid chambers located in the center of the brain. As is known, there are four ventricles—the right and left lateral ventricles, the 3rd ventricle and 4th ventricle—within which the choroid plexus produces cerebral spinal fluid (CSF), approximately 300-500 cc of CSF per day. CSF flows through a series of openings or foramens in the brain and out into the subarachnoid space where it is reabsorbed by the venous system. If the CSF pathways become obstructed or obliterated by developmental or acquired abnormalities, CSF accumulates under pressure within the ventricular system. Such accumulation causes the ventricles to begin to dilate, which causes thinning and stretching of the cerebral mantle.
As will be appreciated, a patient may become symptomatic when the ventricles become enlarged and cause increased pressure and/or stretched fibers in surrounding brain tissue. Although the brain can accommodate ventricular dilation to a certain extend without significant neuronal damage, as this process continues, irreversible brain damage may eventually occur.
The most common treatment for hydrocephalus is the placement of ventriculo-peritoneal shunt (VP shunt) systems. Ventriculo-atrial and ventriculo-pleural shut placements also may be performed in some cases. Typically, VP shunts have three main components: a ventricular catheter, a shunt valve and a distal catheter. The ventricular and distal catheter are typically thin, single lumen tubes with multiple holes at the tip.
VP shunts are typically installed via a surgical procedure in which a small incision is made in the scalp, followed by a small drill hole in the skull to open the dura or outer brain membrane. A ventricular catheter may be then inserted into the lateral ventricle. Because ventricles are located in the center of the brain, an inserted ventricular catheter passes through the brain tissue and only the tip of the ventricular catheter is placed into the ventricle. A shunt valve is thereafter attached to the ventricular catheter to control the pressure resulting from enlarged ventricles. That is, the shunt valve may be opened when intraventricular pressure levels exceed a shunt valve opening pressure so that CSF may be drained at times when the pressure within the brain is found to be elevated (e.g., above a threshold pressure). The shunt valve also may be closed to prevent draining CSF when the pressure is appropriate. A distal (e.g., peritoneal, atrial, or pleural) catheter may be connected to the shunt valve for draining the CSF into the abdominal, atrial, or pleural cavity.
Unfortunately, it is very common for patients with VP shunt systems to undergo multiple surgeries for shunt revision because of a malfunction with or failure in the VP shunt system, which causes the patient to again become symptomatic of hydrocephalus. For example, the frequency of shunt malfunction has been reported to be in the range of 40-60% within the first 5 years of implantation. Obstruction of the ventricular catheter is one of the most common reasons for shunt revision surgeries and accounts up to 75% of all cases of revisions. For example, an obstruction of one or more of the perforation holes in the lumen of the catheter with choroid plexus, brain tissue, a clot, debris, and the like, may occur. Patients also may need to undergo a revision as a result of anatomical changes. For example, as a patient grows (e.g., from a newborn to an adolescent), the size of the head or length of the patient may increase and the installed catheter may become too small and, thus, may move outside of the ventricle or the abdomen.
Although shunt revisions are one of the most commonly performed surgeries in neurosurgery, there are numerous problems that can occur during the surgery. Applicant has realized that such problems may be attributable to the current design and technology regarding ventricular catheters. This may include, for example, frequent repeated obstruction of the catheters. As another example, repeat revisions may require re-puncturing of the brain to place a new ventricular catheter, which risks repeatedly injuring the brain tissue. There also may be some difficulty in placing a new ventricular catheter into small ventricles during the surgery. As such, multiple passes may be needed in these cases, which also may expose the patient to potential brain injury. Additionally, the catheter might be placed suboptimally or outside the ventricle when the ventricles are small. There is also a risk of bleeding and brain injury during the surgery, especially in situations where choroid plexus is sucked in the catheter lumen, the choroid plexus having high vascularity.
Because of these challenges in hydrocephalic patients with small, slit-like ventricles, additional tools and techniques such as neuronavigation, endoscopy, or stereotactic implantation may be needed to enhance the accuracy of ventricular catheter placement and to reduce the rate of ventricular catheter re-obstruction. These tools and techniques, however, significantly prolong the duration of surgery and increase the risk for shunt infection, as well as increasing the cost of surgical intervention.
In view of the above, Applicant has realized that by providing a catheter system that is at least partially permanently implanted in the brain during an initial VP shunt surgery, various advantages may be achieved. To that end, embodiments disclosed herein include a catheter assembly having an sheath that is permanently installed in the brain, with a catheter slidably received in the outer sheath for insertion into the ventricle.
As will be appreciated, by having a permanently installed sheath, the brain need not be punctured during each revision surgery. That is, after the sheath is installed, a physician may simply remove and replace the obstructed catheter during a revision procedure. In such embodiments, the new catheter is placed into the same location in the same ventricle through the permanent passageway created via the sheath. This not only may decrease the risk to brain injury that typically accompanies revision surgeries, such as via repeated puncturing, it also may decrease the risk of bleeding. Such a sheath also may ensure that a passageway to the ventricles always remains open. As such, a physician need not worry whether it will be difficult to place the catheter (e.g., if the ventricle is small) or that the replacement of the catheter will be suboptimal or outside the ventricle. In addition, it is expected that the duration of the revision surgery will be shorter than the standard time for revision surgery, because locating the path is much easier since there is already an installed channel to the ventricle. As will be appreciated, a shorter surgical session is advantageous for the patient. In sum, the disclosed catheter assembly may reduce the complexity and invasiveness of revision surgeries and, thus, may make for an improved patient recovery.
Such a permanent passageway to the ventricle also may allow a physician to drain fluid without having an installed catheter. For example, a physician may drain fluid from the ventricles prior to placement of a new catheter during a revision surgery. The passageway also may allow the physician to conduct an exploration of the ventricles with an endoscope, to fenestrate a membrane, to see the location of the choroid plexus or to determine the appropriate length of the new catheter. For example, the physician may insert an endoscope into the passageway to explore the ventricle prior to placement of a new catheter. As will be appreciated, such steps may be taken without further trauma (e.g., puncture) to the brain.
Additionally, unlike catheters that may become too small and slip out as a patient grows, which may necessitate a revision surgery, Applicant has realized that the disclosed sheath may be installed in a newborn patient and may maintain the permanent passageway into the ventricle, even with growth and age. In other words, the sheath may remain installed in the same patient from infancy to adulthood, with revision surgeries only needed to replace the catheter.
Although the disclosed system may significantly decrease trauma to the brain during revision surgeries, Applicant has realized that some surgeons may still prefer to use existing catheter systems. For example, the sheath may create a slightly larger cross sectional opening in the brain as compared to existing catheter, which may be undesirable. While the catheter assembly may be designed such that diameter of the sheath is the same as the diameter of existing catheters, Applicant believes that the improved surgical experience of the disclosed catheter assembly, even with a larger cross-sectional opening in the brain, will encourage surgeons to not only consider using the assembly but to also adopt the disclosed cather assembly as their preferred treatment option.
According to another aspect, the catheter assembly may be designed to reduce the occurrence of catheter obstructions. For example, while existing ventricular catheters may be used in the assembly, the assembly also may include a newly designed catheter. Such a newly designed catheter may include one or more side-openings in the catheter wall at the ventricular (e.g., distal) end, which may include a slit or fenestration hole having any desired shape such as an elongated opening, a slit opening, an eye-drop shaped opening, circular holes, or other suitable shapes or combinations of shapes. Such newly designed catheters also may include one or more lumens (e.g., 3-4 lumens) located at a distal end, the one or more lumens being in communication with a central lumen extending along a remainder of the length of the catheter. As will be appreciated, in such embodiments, if one of the lumens becomes obstructed, such as via a clot, CSF may still pass through one or more of the other lumens at the distal end of the catheter to the central catheter lumen.
According to still another aspect, a distal catheter assembly that is connected to the shunt valve for draining the CSF into the abdominal, atrial, or pleural cavity is disclosed. As is known, traditional catheters used to drain CSF include a tube with a single lumen and openings at the tip and/or side. Such catheters typically extends from the brain to the abdominal cavity and are positioned subcutaneously in the neck, chest and/or abdominal wall. Without wishing to be bound by theory, these catheters may become calcified over time, may become attached to the subcutaneous tissue, may need to be replaced when they become broken, obstructed and/or shortened. Traditionally, surgery to remove an old distal catheter includes multiple incisions on the head, neck, chest and/or abdomen to remove old catheter pieces (e.g., piece by piece). Alternatively, the old, broken distal catheter may be left in place, with a new catheter being inserted subcutaneously to form a new, second tract. In other words, the patient would live with the old and new catheters under his or her skin.
To that end, and similar to the catheter assembly, Applicant has realized that by providing a distal catheter assembly that is at least partially permanently implanted in the neck, chest, and/or abdomen, advantages may be realized. As such, embodiments disclosed herein comprises a VP shut with a catheter assembly attached to the brain, a shunt valve and a distal catheter assembly that connects the shunt valve to the neck, chest and/or abdomen. In some embodiments, the distal catheter assembly includes a distal sheath and a distal catheter that is slidably received in the distal sheath. Such a distal catheter may be placed under the skin with contact between the head and abdominal incision via a shut tunneler In use, to replace the catheter, the physician need only remove the distal catheter, while the distal sheath remains attached to the body.
As will be appreciated, having such a permanent subcutaneous path (e.g., the distal sheath) from the shunt valve located at the head to abdominal cavity, may afford an opportunity to remove/replace abdominal catheters through a small incision at the head. In such an embodiment, a new abdominal catheter may be placed through this incision without having to open an abdominal incision and without re-entering the abdominal cavity.
Turning now to the figures,
As shown in
For purposes herein the sheath includes an outer covering that is placed over the catheter. In some embodiments, the sheath may be cylindrical in shape, although it will be appreciated that the sheath may have other shapes. As shown in this
Turning back to
In some embodiments, as illustrated in
In some embodiments, as shown in
In some embodiments, as shown in
Turning back to
In some embodiments, the length of the sheath may be determined based on the patient's head size and age. For example, the sheath length may be between about 2 cm and 10 cm installed. As will be appreciated, the uninstalled sheath may be between about 10 and 20 cm, such that the surgeon may cut the sheath to the needed size.
In some embodiments, the length of the installed catheter is between about 4 cm and 12 cm. As with the sheath, the installed length will depend on the patient's age and head size and may be provided in a length of approximately 12-22 cm, such that the surgeon may cut the catheter to size.
As shown in
In one illustrative embodiment, the outer diameter D3 of the port 216 (e.g., the outer diameter of the distal end 217 of the inner connection portion 208) may be about 3 mm and the inner diameter D2 of the sheath 202 may be about 3 mm, so that a press fit can be achieved. As will be appreciated, other suitable connections may be used to join the sheath and inner connection portion. In other embodiments, the sheath and outer connection portion also may be integrally formed. In one embodiment, a length of the sheath placed over the proximal end of the outer connection portion is about 5 mm.
In some embodiments, the inner connection portion 208 fits a drill hole in the skull of the patient and is attached to the patient. Once installed, the inner portion 208 and the sheath 202 may be permanently installed and, thus, not be removed except under unusual conditions, for example if there is an infection present.
In some embodiment, a diameter of the port 223 is greater than the inner diameter of the catheter 204 such that the catheter is unlikely to come loose during use. In one illustrative embodiment, the inner diameter of the catheter 204 is 1.2 mm while the diameter of the port 223 is 1.4 mm. In some embodiments, a length of the catheter placed over the proximal end of the outer connection portion is about 3 mm. In some embodiments, the catheter may be inserted into the ventricle by passing the catheter through the sheath 202, with the outer connection portion 206 attached to the catheter 204. Next, the outer connector portion 206 may be snugly inserted into the inner connection portion 208, thus completing the installation of the shunt.
As also shown in
The outer connection portion 206 also may include a plurality of holes or other openings 210 that permit withdrawal of fluid from the space between the sheath 202 and the catheter 204. In some embodiments, the portion of the outer connection portion 206 having the openings 210 may be about 4 mm in diameter and maybe semi-hemispherical in shape. As previously described, the outer connection 206 also may include a port 223 at the distal end 221 for allowing withdrawal of fluid from the catheter 202.
As shown in
As shown in
In some embodiments, the catheter 204 allows CSF drainage through wall slits and one or multiple elongated or ellipsoid openings at the tip. Multiple channels can be connected to a wide variety of ellipsoid openings. As will be appreciated, known catheters tiny holes. The ellipsoid openings and slit walls may minimize aspiration of tissues into the catheter lumen, and decrease risk of catheter obstruction.
According to another aspect, as illustrated in
In embodiments in which the catheter is snugly fit within the sheath and a connector is not used, as shown in
According to another embodiment, a method of removing replacing the catheter in instances of a catheter are disclosed. Such a method 400 is shown in the flow chart of
According to another aspect, a distal catheter assembly is disclosed. As shown in
As is known, catheters calcify over time and may break, become obstructed, separate or become shortened. Applicant has realized that by creating a permanent subcutaneous passageway, similar to the permanent passageway created in the brain, advantages may be realized. To that end, and as shown in
As shown in
According to another embodiment, a method of removing and replacing an obstructed distal catheter is disclosed. In such an embodiment, the method may include opening at the head around the shunt valve, disconnecting the sheath and catheter from shunt valve, pulling out the distal catheter without removing the distal sheath and slidably inserting a new abdominal catheter through the distal sheath from the same incision in the head. As will be appreciated, because there is a permanent path from head to the abdominal cavity through the previously placed distal sheath, additional incisions need not be made in the patient.
In some embodiments, the distal catheter may have an outer diameter of between about 2 mm and 3 mm or about 2.5 mm. The inner diameter may be between about 1 mm and 2 mm or about 1.5 mm. As will be appreciated, the wall thickness may be between about 0.3 mm and 0.8 mm or about 0.5 mm. The installed length will also depend on the patient's age and body size and may range between about 60 cm and 90 cm, and may be cut to size from a catheter that is between about 70 and 100 cm in length, or about 90 cm in length.
In some embodiments, the distal sheath may have an outer diameter of between about 2.5 mm to 3.6 mm or about 2.6 mm. The inner diameter may be between about 2.1 mm and 3.1 mm. The wall thickness may be between about 0.3 and 0.6 mm, or about 0.5 mm. The length of the sheath also may be between about 50 cm to 70 cm installed, although this length with vary based on the age and size of the patient. The sheath may be cut to size from a sheath that is between about 70 and 100 cm in length, or about 90 cm in length.
While the ventricular catheter assembly can be used as part of a ventriculo-peritoneal shunt, it can also be used to remove fluid that is then delivered to locations other than the abdomen of the patient, e.g., as part of an external ventricular drainage system.
Also, although the catheter assembly has been disclosed for use in removing fluid in the brain, it will be appreciated, that the catheter assembly may be installed in other location of the body to remove other fluids.
Although the theoretical description given herein is thought to be correct, the operation of the devices described and claimed herein does not depend upon the accuracy or validity of the theoretical description. That is, later theoretical developments that may explain the observed results on a basis different from the theory presented herein will not detract from the inventions described herein.
Any patent, patent application, patent application publication, journal article, book, published paper, or other publicly available material identified in the specification is hereby incorporated by reference herein in its entirety. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material explicitly set forth herein is only incorporated to the extent that no conflict arises between that incorporated material and the present disclosure material. In the event of a conflict, the conflict is to be resolved in favor of the present disclosure as the preferred disclosure.
While the present teachings have been described in conjunction with various embodiments and examples, it is not intended that the present teachings be limited to such embodiments or examples. On the contrary, the present teachings encompass various alternatives, modifications, and equivalents, as will be appreciated by those of skill in the art. Accordingly, the foregoing description and drawings are by way of example only.
Various aspects of the present invention may be used alone, in combination, or in a variety of arrangements not specifically discussed in the embodiments described in the foregoing and is therefore not limited in its application to the details and arrangement of components set forth in the foregoing description or illustrated in the drawings. For example, aspects described in one embodiment may be combined in any manner with aspects described in other embodiments.
Also, the invention may be embodied as a method, of which an example has been provided. The acts performed as part of the method may be ordered in any suitable way. Accordingly, embodiments may be constructed in which acts are performed in an order different than illustrated, which may include performing some acts simultaneously, even though shown as sequential acts in illustrative embodiments.
Use of ordinal terms such as “first,” “second,” “third,” etc., in the claims to modify a claim element does not by itself connote any priority, precedence, or order of one claim element over another or the temporal order in which acts of a method are performed, but are used merely as labels to distinguish one claim element having a certain name from another element having a same name (but for use of the ordinal term) to distinguish the claim elements.
Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having,” “containing,” “involving,” and variations thereof herein, is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.
This application claims the benefit under 35 U.S.C. § 119(e) to U.S. Provisional Application Ser. No. 62/169,186, entitled “VENTRICULAR SHUT CATHETER ASSEMBLY AND METHOD OF VENTRICULAR CATHETER REPLACEMENT,” filed on Jun. 1, 2015, which is herein incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US16/35211 | 6/1/2016 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62169186 | Jun 2015 | US |